Panagene Inc

Panagene Inc. develops molecular diagnostics products in South Korea. Its offerings include liquid biopsy products for lung and colon cancers, and tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases. The company also provides products for cervical cancer, sexually transmitted diseases, and extreme drug resistance, along with peptide nucleic acid products. Formerly known as Koram Panagene Ltd., it changed its name to Panagene Inc. in January 2009, was incorporated in 1976, and is based in Daejeon, South Korea.